Oncolytics Biotech (ONCY) Change in Taxes (2009 - 2013)
Oncolytics Biotech's (ONCY) quarterly Change in Taxes came in at $33600.0 in Q4 2013, up 10.26% year-on-year from $30474.0 in Q4 2012, and up 10.26% on a QoQ basis from $30474.0 in Q4 2012.
Oncolytics Biotech (ONCY) Change in Taxes (2009 - 2013) Analysis & Trends
Oncolytics Biotech (ONCY) has 5 years of Change in Taxes data on file, last reported at $33600.0 in Q4 2013.
- On a quarterly basis, Change in Taxes rose 10.26% year-over-year to $33600.0 in Q4 2013; TTM through Dec 2013 was $111685.0, a 12.9% increase from a year earlier, with the FY2013 full-year figure at $33600.0, up 10.26% from the prior year.
- Change in Taxes for Q4 2013 stood at $33600.0, up from $30474.0 in the prior quarter.
- Over the last five years, Change in Taxes for ONCY reached as high as $40000.0 in Q4 2011 and fell as low as $7611.0 in Q4 2010.
- Historically, Change in Taxes has averaged $26504.4 across 5 years, with a median of $30474.0 in 2012.
- Across the five-year window, Change in Taxes sank 63.47% in 2010 and soared 425.56% in 2011, its largest moves.
- Year by year, Change in Taxes stood at $20836.8 in 2009, then sank by 63.47% to $7611.0 in 2010, then surged by 425.56% to $40000.0 in 2011, then fell by 23.82% to $30474.0 in 2012, then increased by 10.26% to $33600.0 in 2013.
- Per Business Quant data, the three most recent Change in Taxes figures were $33600.0 in Q4 2013, $30474.0 in Q4 2012, and $40000.0 in Q4 2011.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -8,939.03 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Oncolytics Biotech | 372.40 Mn | 372.40 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2013 | 33,600.00 |
| Dec 31, 2013 | 33,600.00 |
| Dec 31, 2012 | 30,474.00 |
| Dec 31, 2012 | 30,474.00 |
| Dec 31, 2011 | 40,000.00 |
| Dec 31, 2011 | 40,000.00 |
| Dec 31, 2010 | 7,611.00 |
| Dec 31, 2010 | 7,611.00 |
| Dec 31, 2009 | 20,836.80 |
| Dec 31, 2009 | 20,836.80 |